Abstract RF3-01: TBCRC 056: A Phase II Study of Neoadjuvant Niraparib with Dostarlimab for Patients with BRCA- or PALB2-mutated Breast Cancer: Results From the ER+/HER2- Cohort
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Erica Mayer, Noah Graham, Roberto A. Leon-Ferre, Mariya Rozenblit, Cesar Santa-Maria, Steven Isakoff, Jennifer Specht, Nadine Tung, Vandana Abramson, Jennifer Desrosiers, Beyza Koca, Sara M. Tolaney, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Geoffrey I. Shapiro, Nabihah Tayob, Jennifer L. Guerriero
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411287635